Literature DB >> 25877189

Health: Make precision medicine work for cancer care.

Mark A Rubin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25877189     DOI： 10.1038/520290a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Authors:  D J Slamon; B Leyland-Jones; S Shak; H Fuchs; V Paton; A Bajamonde; T Fleming; W Eiermann; J Wolter; M Pegram; J Baselga; L Norton
Journal:  N Engl J Med       Date:  2001-03-15       Impact factor: 91.245

2.  Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.

Authors:  R M Hudziak; J Schlessinger; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Inhibition of mutated, activated BRAF in metastatic melanoma.

Authors:  Keith T Flaherty; Igor Puzanov; Kevin B Kim; Antoni Ribas; Grant A McArthur; Jeffrey A Sosman; Peter J O'Dwyer; Richard J Lee; Joseph F Grippo; Keith Nolop; Paul B Chapman
Journal:  N Engl J Med       Date:  2010-08-26       Impact factor: 91.245

4.  Adjuvant trastuzumab in HER2-positive breast cancer.

Authors:  Dennis Slamon; Wolfgang Eiermann; Nicholas Robert; Tadeusz Pienkowski; Miguel Martin; Michael Press; John Mackey; John Glaspy; Arlene Chan; Marek Pawlicki; Tamas Pinter; Vicente Valero; Mei-Ching Liu; Guido Sauter; Gunter von Minckwitz; Frances Visco; Valerie Bee; Marc Buyse; Belguendouz Bendahmane; Isabelle Tabah-Fisch; Mary-Ann Lindsay; Alessandro Riva; John Crown
Journal:  N Engl J Med       Date:  2011-10-06       Impact factor: 91.245

5.  Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase.

Authors:  Sridhar K Rabindran; Carolyn M Discafani; Edward C Rosfjord; Michelle Baxter; M Brawner Floyd; Jonathan Golas; William A Hallett; Bernard D Johnson; Ramaswamy Nilakantan; Elsebe Overbeek; Marvin F Reich; Ru Shen; Xiaoqing Shi; Hwei-Ru Tsou; Yu-Fen Wang; Allan Wissner
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

6.  Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

Authors:  C R King; M H Kraus; S A Aaronson
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

7.  Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation.

Authors:  Fang Wang; Jeremy Travins; Byron DeLaBarre; Virginie Penard-Lacronique; Stefanie Schalm; Erica Hansen; Kimberly Straley; Andrew Kernytsky; Wei Liu; Camelia Gliser; Hua Yang; Stefan Gross; Erin Artin; Veronique Saada; Elena Mylonas; Cyril Quivoron; Janeta Popovici-Muller; Jeffrey O Saunders; Francesco G Salituro; Shunqi Yan; Stuart Murray; Wentao Wei; Yi Gao; Lenny Dang; Marion Dorsch; Sam Agresta; David P Schenkein; Scott A Biller; Shinsan M Su; Stephane de Botton; Katharine E Yen
Journal:  Science       Date:  2013-04-04       Impact factor: 63.714

8.  Changing the research landscape: the New York City Clinical Data Research Network.

Authors:  Rainu Kaushal; George Hripcsak; Deborah D Ascheim; Toby Bloom; Thomas R Campion; Arthur L Caplan; Brian P Currie; Thomas Check; Emme Levin Deland; Marc N Gourevitch; Raffaella Hart; Carol R Horowitz; Isaac Kastenbaum; Arthur Aaron Levin; Alexander F H Low; Paul Meissner; Parsa Mirhaji; Harold A Pincus; Charles Scaglione; Donna Shelley; Jonathan N Tobin
Journal:  J Am Med Inform Assoc       Date:  2014-05-12       Impact factor: 4.497
  8 in total
  23 in total

Review 1.  [Establishment of a living biobank : Improved guidance of precision cancer care with in vitro and in vivo cancer models].

Authors:  C Pauli; H Moch; M A Rubin
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

2.  Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.

Authors:  Chantal Pauli; Benjamin D Hopkins; Davide Prandi; Reid Shaw; Tarcisio Fedrizzi; Andrea Sboner; Verena Sailer; Michael Augello; Loredana Puca; Rachele Rosati; Terra J McNary; Yelena Churakova; Cynthia Cheung; Joanna Triscott; David Pisapia; Rema Rao; Juan Miguel Mosquera; Brian Robinson; Bishoy M Faltas; Brooke E Emerling; Vijayakrishna K Gadi; Brady Bernard; Olivier Elemento; Himisha Beltran; Francesca Demichelis; Christopher J Kemp; Carla Grandori; Lewis C Cantley; Mark A Rubin
Journal:  Cancer Discov       Date:  2017-03-22       Impact factor: 39.397

3.  Precision medicine with electronic medical records: from the patients and for the patients.

Authors:  Losiana Nayak; Indrani Ray; Rajat K De
Journal:  Ann Transl Med       Date:  2016-10

4.  Comprehensive anticancer drug response prediction based on a simple cell line-drug complex network model.

Authors:  Dong Wei; Chuanying Liu; Xiaoqi Zheng; Yushuang Li
Journal:  BMC Bioinformatics       Date:  2019-01-22       Impact factor: 3.169

5.  Challenges influencing next generation technologies for precision medicine.

Authors:  Hyungsoon Im; Hakho Lee; Cesar M Castro
Journal:  Expert Rev Precis Med Drug Dev       Date:  2016-03-28

6.  Implementing and Improving Automated Electronic Tumor Molecular Profiling.

Authors:  Matthew J Rioth; David B Staggs; Lauren Hackett; Erich Haberman; Mike Tod; Mia Levy; Jeremy Warner
Journal:  J Oncol Pract       Date:  2016-01-26       Impact factor: 3.840

7.  The prognostic potential of alternative transcript isoforms across human tumors.

Authors:  Juan L Trincado; E Sebestyén; A Pagés; E Eyras
Journal:  Genome Med       Date:  2016-08-17       Impact factor: 11.117

Review 8.  Public data and open source tools for multi-assay genomic investigation of disease.

Authors:  Lavanya Kannan; Marcel Ramos; Angela Re; Nehme El-Hachem; Zhaleh Safikhani; Deena M A Gendoo; Sean Davis; David Gomez-Cabrero; Robert Castelo; Kasper D Hansen; Vincent J Carey; Martin Morgan; Aedín C Culhane; Benjamin Haibe-Kains; Levi Waldron
Journal:  Brief Bioinform       Date:  2015-10-12       Impact factor: 11.622

9.  Prognostic impact of mutation profiling in patients with stage II and III colon cancer.

Authors:  Yinchen Shen; Xiaohong Han; Jianfei Wang; Shuai Wang; Hongying Yang; Shih-Hsin Lu; Yuankai Shi
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

Review 10.  Computational models for predicting drug responses in cancer research.

Authors:  Francisco Azuaje
Journal:  Brief Bioinform       Date:  2017-09-01       Impact factor: 11.622
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.